Checked.be · Company dossierhttps://checked.be/en/c/akv-pharma-0644617062 · as of 18-11-2026
AKV PHARMA
ActivePrivate limited company (pre-2019) · founded 2015 · active for 10 yearsKoolskampstraat 69, 8740 PittemKBO/BCE: BE 0644.617.062subsidiary of Hidden nameVisible after signing in
Save to list
Keep companies in your own lists to find and compare them later. All it takes is a free account.
2 directorsName after signing inVisible after signing in and 1 other
Documentsfilings and deeds
23-06-202638 days before the deadline
2025micro format
Gross margin from €35,082 to €40,416Result from €8,515 to €25,201Equity from €27,219 to €52,420Debts from €117,618 to €6,144Cash from €40,795 to €57,661
Higher solvency than 93% of companies in retail trade. Sector median 33.3% · 25,338 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 34,726 companies had the same profile as AKV PHARMA has now. Each dot stands for 87 companies, two years later.
95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
Micro
10 to 20 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,726 companies, not a prediction for AKV PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Board and ownership
Hidden nameVisible after signing in
Director, Name after signing inVisible after signing in, since 01-04-2026
Name hiddenVisible after signing in 100%score XXVisible after signing inequity €354,554 (2026) · annual accounts 31-03-2026 of Name after signing inVisible after signing in
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0644617062
Registered office moved from Bruges to Pittem
The registered office moved from Fazantenlaan 13, 8200 Brugge to Koolskampstraat 69, 8740 Pittem · Name hiddenVisible after signing in resigns as director · Hidden nameVisible after signing in appointed as director · General meeting of 01-04-2026 · Gazette deed
New directorName after signing inVisible after signing in appointed, Name hiddenVisible after signing in resigned · Director discharge: Hidden nameVisible after signing in · General meeting of 07-03-2023 · Gazette deed
Registered office moved to Bruges
The registered office moved to Fazantenlaan 13, 8000 Brugge, België · Board meeting of 30-03-2020 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as AKV PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €52,900 and €70,300, founded between 2015 and 2018.
The company number of AKV PHARMA is 0644.617.062. The VAT number is the same number with BE in front: BE 0644.617.062.
Where is AKV PHARMA based?
The registered office is at Koolskampstraat 69, 8740 Pittem.Company details
What does AKV PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of AKV PHARMA?
AKV PHARMA is a private limited company (pre-2019) (BVBA).
When was AKV PHARMA founded?
AKV PHARMA was founded on 17-12-2015.
Is AKV PHARMA still active?
Yes, AKV PHARMA is an active enterprise in the KBO register.
How many employees does AKV PHARMA have?
AKV PHARMA had an average of 1.9 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of AKV PHARMA?
The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €40,416 and 56 comparable companies (NACE 477). It probably lies between €100,000 and €330,000.
Is AKV PHARMA profitable?
In financial year 2025, AKV PHARMA made a profit of €25,201.
Where can I find the annual accounts of AKV PHARMA?
AKV PHARMA filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of AKV PHARMA due?
AKV PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline